Zobrazeno 1 - 10
of 298
pro vyhledávání: '"J, Berenson"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
H. Yang, T. Facon, Maria-Victoria Mateos, P. Moreau, K. Iskander, David S. Siegel, R.Z. Orlowski, H. Ma, Noopur Raje, Z. Klippel, K. Mezzi, A. Zahlten-Kumeli, J.G. Berdeja, Meletios-Athanasios Dimopoulos, J. Berenson, Alexander Keith Stewart
Publikováno v:
HemaSphere. 3:260
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c06f4aa1eaa67e2008fa1e5531ec552
https://doi.org/10.1097/01.hs9.0000560736.46354.bc
https://doi.org/10.1097/01.hs9.0000560736.46354.bc
Autor:
William A. Wargin, Lynne Neumayr, Richard J. Labotka, Marvin Reid, Jeffrey R. Keefer, Kenneth I. Ataga, Ronald J. Berenson, Jonathan Glass, Abdullah Kutlar, Loray A Blair-Britt, Susan P. Perrine, Elliott Vichinsky
Publikováno v:
American Journal of Hematology. 87:1017-1021
Therapeutics which reduce the pathology in sickle cell syndromes are needed, particularly noncytotoxic therapeutics. Fetal hemoglobin (HbF, α(2) γ(2) ) is established as a major regulator of disease severity; increased HbF levels correlate with mil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52646293447c428c4fff45a62f7446a2
https://doi.org/10.1002/ajh.23306
https://doi.org/10.1002/ajh.23306
Autor:
Zong-Yi Li, Qinghua Feng, Maximilian Richter, André Lieber, Hua Cao, Darrick Carter, Roma Yumul, Jonas Persson, Ines Beyer, Hui Song, Ruan van Rensburg, Charles W. Drescher, Ronald J. Berenson, Steve R. Roffler
Publikováno v:
Clinical Cancer Research. 18:3340-3351
Purpose: Epithelial junctions between tumor cells inhibit the penetration of anticancer drugs into tumors. We previously reported on recombinant adenovirus serotype 3–derived protein (JO-1), which triggers transient opening of intercellular junctio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8921f580789dfd1179d66e1ce87cf45b
https://doi.org/10.1158/1078-0432.ccr-11-3213
https://doi.org/10.1158/1078-0432.ccr-11-3213
Autor:
Gunilla B. Karlsson Hedestam, André Lieber, William C. Adams, Richard A. Koup, Ronald J. Berenson, Karin Loré
Publikováno v:
J Gen Virol
The complement-regulatory protein CD46 is the primary receptor for human adenovirus type 35 (HAdV-35) and can regulate human immune-cell activation. CD4 + T-cells are critical for initiating and maintaining adaptive immunity elicited by infection or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e189e1505780f6f24ee26b216ba8ed7
https://doi.org/10.1099/vir.0.039222-0
https://doi.org/10.1099/vir.0.039222-0
Autor:
Ronald J. Berenson, Douglas V. Faller, David H.K. Chui, Serguei A. Castaneda, Noppadol Siritanaratku, Susan P. Perrine, Suthat Fucharoen
Publikováno v:
Annals of the New York Academy of Sciences. 1202:158-164
Inducing expression of endogenous fetal globin (gamma-globin) gene expression to 60-70% of alpha globin synthesis produces beta-thalassemia trait globin synthetic ratios and can reduce anemia to a mild level. Several classes of therapeutics have indu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38290d4562fc797cba0415ae2ec6f5bb
https://doi.org/10.1111/j.1749-6632.2010.05593.x
https://doi.org/10.1111/j.1749-6632.2010.05593.x
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S. A. Long, Ruth Taniguchi, Jane H. Buckner, Ronald J. Berenson, Mark Bonyhadi, Dale Kalamasz
Publikováno v:
Journal of Immunotherapy. 27:405-418
T-cell receptor engagement and accompanying costimulatory signals control the level of activation and functional potential of individual T cells. The authors previously developed a novel technology in which human T cells are activated and expanded in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c82641ad34197997ea46ce6445417f
https://doi.org/10.1097/00002371-200409000-00010
https://doi.org/10.1097/00002371-200409000-00010
Autor:
S. Noga, M. White, M. Benyunes, Heather Tully, O. Ballester, Jacinta Meharchard, R. Schlossman, Alexander Keith Stewart, R. Berenson, F. Sahebi, Hope S. Rugo, S. Tarantolo, C. G. Jacobs, Edward A. Stadtmauer, R. Brown, P. Stiff, G. Schiller, C. Freytes, R. Vescio, K. C. Anderson, J. Berenson, John F. DiPersio
Publikováno v:
Journal of Clinical Oncology. 19:3771-3779
PURPOSE: Although high-dose chemotherapy supported by autologous peripheral-blood progenitor-cell (PBPC) transplantation improves response rates and survival for patients with multiple myeloma, all patients eventually develop progressive disease afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af858cebcd63cc94e704e6481197a0b0
https://doi.org/10.1200/jco.2001.19.17.3771
https://doi.org/10.1200/jco.2001.19.17.3771